Skip to main content
Medical information Clinical review pending

Genetic Testing

LIPA Gene Wolman Disease Genetic Test

Genetic test using Next-Generation Sequencing (NGS) to detect mutations in the LIPA gene, aiding in the diagnosis of Wolman disease, a rare metabolic disorder.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
A blood sample is required for this test. Confirm with the laboratory before booking.
Results
Confirm with the laboratory before booking.
Preparation
No special preparation is typically required for this blood test. Confirm with the laboratory before booking.
Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the LIPA Gene Wolman Disease Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Individuals presenting with symptoms suggestive of Wolman disease (e.g., failure to thrive, enlarged liver and spleen, vomiting, diarrhea).
  • ✓Newborn screening follow-up for suspected lysosomal acid lipase deficiency.
  • ✓Individuals with a family history of Wolman disease or related metabolic disorders.
  • ✓Genetic counseling for families affected by Wolman disease.
  • ✓Prenatal diagnosis in families with a known LIPA gene mutation.
02

In plain language

What this test helps you understand

This test helps confirm or rule out a diagnosis of Wolman disease by identifying specific mutations in the LIPA gene. It is used for individuals suspected of having the condition based on clinical symptoms or family history.
The LIPA Gene Wolman Disease NGS Genetic DNA Test is a specialized genetic test designed to identify mutations in the LIPA gene. This gene provides instructions for making an enzyme essential for breaking down certain fats (lipids) in the body. Mutations in this gene cause Wolman disease, a rare and severe metabolic disorder that affects multiple organs, particularly the liver, spleen, and adrenal glands. This test utilizes advanced Next-Generation Sequencing (NGS) technology to analyze the LIPA gene for variations that may cause the disease. Early diagnosis is crucial for managing Wolman disease and improving patient outcomes. This test provides valuable genetic information for patients and healthcare providers.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo special preparation is typically required for this blood test. Confirm with the laboratory before booking.
SampleA blood sample is required for this test. Confirm with the laboratory before booking.
MethodologyNext-Generation Sequencing (NGS) is used to analyze the LIPA gene.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test analyzes the LIPA gene for known disease-causing mutations. It may not detect all possible mutations or variants of uncertain significance. Results should be interpreted in the context of clinical findings and family history. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Wolman disease is a rare, inherited metabolic disorder caused by mutations in the LIPA gene. It affects the body's ability to break down certain fats, leading to serious health problems.
Testing is recommended for individuals with symptoms like poor growth, enlarged liver/spleen, or a family history of the condition. Consult your doctor.
The test uses advanced NGS technology for accurate detection of LIPA gene mutations. However, limitations exist, and results should be interpreted by a healthcare professional.
Results are typically provided within a few weeks. A genetic counselor or physician will explain the findings and their implications.
Insurance coverage varies. Please check with your insurance provider regarding coverage for genetic testing.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp